Clinical Trials Directory

Trials / Completed

CompletedNCT05722067

Improvement of Fertilization Rate and Embryo Quality by Treating Calcium Ionophore in IVF Patients: a Sibling Oocyte Control Study

Improved the Low Fertilization Rates and Increased the High-quality Embryogenesis by Treatment With Calcium Ionophore GM508 CultActive Optimized Medium in Vitro Fertilization (IVF) Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
Female
Age
20 Years – 50 Years
Healthy volunteers
Not accepted

Summary

GM508 CultActive is a bicarbonate buffered reagent and ready-to-use designed to investigate oocytes of patients with failed fertilization after previous Intracytoplasmatic Sperm Injection cycles. The investigators hypothesize that GM508 CultActive will improve the fertilization rate and embryo development of such IVF patients (a history of poor fertilization, a history of poor embryo quality, and over 40 years old expected challenging to conceive).

Conditions

Interventions

TypeNameDescription
OTHERcalcium ionophoreThe intervention group will be treated with a ready-to-use ionophore medium (GM508 CultActive, Gynemed) within 15 min after ICSI (or 18 min in IVF) based on the situation of sperm. After 15 min of incubation in GM508 CultActive and a thorough washing process, the oocytes will be cultured in the same protocol as the control group.

Timeline

Start date
2023-01-01
Primary completion
2025-03-23
Completion
2025-06-30
First posted
2023-02-10
Last updated
2026-03-20

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05722067. Inclusion in this directory is not an endorsement.